Teva Pharmaceutical Industries Total Long Term Liabilities 2010-2024 | TEVA
Teva Pharmaceutical Industries total long term liabilities for the quarter ending September 30, 2024 were $21.577B, a 6.92% decline year-over-year.
- Teva Pharmaceutical Industries total long term liabilities for 2023 were $23.106B, a 3.5% decline from 2022.
- Teva Pharmaceutical Industries total long term liabilities for 2022 were $23.945B, a 5.71% decline from 2021.
- Teva Pharmaceutical Industries total long term liabilities for 2021 were $25.395B, a 3.86% decline from 2020.